Longitudinal Functional Study of Murine Aging: A Resource for Future Study Designs

Daniel S Evans1, Monique N O'Leary2, Ryan Murphy2

  • 1California Pacific Medical Center Research Institute San Francisco CA USA.

JBMR Plus
|March 29, 2021
PubMed

Insights

Benzoxazole, a compound extending lifespan in worms, was found to slow age-related bone loss in mice. This study provides insights into preclinical aging and therapeutic interventions for age-related diseases.

Area of Science:

  • Gerontology and regenerative medicine
  • Preclinical models of aging
  • Skeletal aging and bone metabolism

Background:

  • Aging is a complex process involving systemic declines in tissue and organ function.
  • Interventions that mitigate aging processes could prevent age-related diseases and enhance quality of life.
  • Mouse models are crucial for studying aging and testing potential therapeutic interventions.

Purpose of the Study:

  • To evaluate the efficacy of interventions associated with lifespan extension or age-related disease improvement in mouse models.
  • To assess the impact of these interventions on a broad spectrum of functional aging assays.
  • To establish reference rates of change for key aging parameters in mice.

Main Methods:

  • Testing of several interventions, including Benzoxazole, in mouse models.
  • Comprehensive functional assays measuring parameters like kyphosis, blood glucose, body composition, activity, and metabolic measures.
  • Detailed analysis of skeletal aging parameters in bone.

Main Results:

  • Benzoxazole demonstrated a significant effect in slowing age-related femoral bone loss in mice.
  • Rates of change for various aging biomarkers were established in untreated mice.
  • An online application was developed to aid in calculating power and variance for aging metrics.

Conclusions:

  • Interventions targeting aging processes can be effectively studied in mouse models.
  • Benzoxazole shows potential as a therapeutic agent for mitigating age-related bone loss.
  • The developed resource aids in the design of future preclinical aging studies and intervention trials.